Clarus Therapeutics Holdings Inc. (NASDAQ:CRXT) saw an upside of 38.45% to $5.68 after adding $1.58 on Wednesday. The 5-day average trading volume is 1,316,101 shares of the company’s common stock. It has gained $6.10 in the past week. An average of 1,229,525 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 1,407,408.
CRXT’s 1-month performance is -46.05% or -$1.63 on its low of $3.43 reached on 10/07/21. The company’s shares have touched a 52-week low of $3.43 and high of $31.24. YTD, CRXT has lost -59.72%. However, the current price is down -81.83%% from the 52-week high price.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
CRXT stock has a beta of 0.00. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 8.72 while the price-to-book (PB) in the most recent quarter is 0.61.
Clarus Therapeutics Holdings Inc.’s quick ratio for the recent quarter was 0.30, with the current ratio over the same period at 0.30 meaning that CRXT stock is not able to fulfill its debt obligations.
CRXT stock balance sheet for the recent quarter shows that total liabilities totaled 53.99 million, with total debt at $149.43 million. Shareholders hold equity totaling $7.25 million
Let’s look briefly at Clarus Therapeutics Holdings Inc. (CRXT) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 59.88% to suggest the stock is trending Neutral, with historical volatility in this time period at 253.31%.
The stock’s 5-day moving average is $4.24, reflecting a +57.11% or $2.17 change from its current price. CRXT is currently trading -19.43% above its 20-day SMA, -40.54% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -41.24%.
Stochastic %K and %D was 35.80% and 17.43% and the average true range (ATR) pointed at 0.86. The RSI (14) points at 50.94%, while the 14-day stochastic is at 82.74% with the period’s ATR at 0.93. The stock’s 9-day MACD Oscillator is pointing at 0.45 and -0.05 on the 14-day charts.
Analysts offering their rating for CRXT stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate CRXT as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 4 have offered a “buy” rating.
What is CRXT’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $12.00 and a high of $20.00, with their median price target at $12.50. Looking at these predictions, the average price target given by analysts is for Clarus Therapeutics Holdings Inc. (CRXT) stock is $14.25.